Functional expression of human P-glycoprotein in Schizosaccharomyces pombe

FEBS Lett. 1993 Sep 20;330(3):279-82. doi: 10.1016/0014-5793(93)80888-2.

Abstract

Human MDR1 cDNA was introduced into the human cultured cells KB-3-1 and Schizosaccharomyces pombe pmd1 null mutant KN3. The drug sensitivity of KB-G2 and KN3/pgp, expressing human P-glycoprotein, was examined. KB-G2 was resistant to the peptide antibiotics valinomycin and gramicidin D as well as having a typical multidrug resistance (MDR) phenotype. KN3/pgp was resistant to valinomycin and actinomycin D, but not to adriamycin. The ATP-hydrolysis-deficient mutant did not confer KN3 resistance to these antibiotics. Human P-glycoprotein expressed in S. pombe seemed to lack N-glycosylation. The N-glycosylation-deficient mutant, however, conferred a typical MDR phenotype on KB-3-1. These results suggest that human P-glycoprotein functions as an efflux pump of valinomycin and actinomycin D in the membrane of S. pombe.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • ATP Binding Cassette Transporter, Subfamily B, Member 1
  • Adenosine Triphosphate / metabolism
  • Base Sequence
  • Carrier Proteins / genetics*
  • Cells, Cultured
  • Cloning, Molecular
  • DNA
  • Dactinomycin / pharmacology
  • Doxorubicin / pharmacology
  • Drug Resistance / genetics
  • Gramicidin / pharmacology
  • Humans
  • Hydrolysis
  • Membrane Glycoproteins / genetics*
  • Microbial Sensitivity Tests
  • Molecular Sequence Data
  • Mutation
  • Schizosaccharomyces / genetics*
  • Valinomycin / pharmacology

Substances

  • ATP Binding Cassette Transporter, Subfamily B, Member 1
  • Carrier Proteins
  • Membrane Glycoproteins
  • Gramicidin
  • Dactinomycin
  • Valinomycin
  • Doxorubicin
  • Adenosine Triphosphate
  • DNA